๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Coronary Artery Disease
Clinical trial register · China

Coronary Artery Disease Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 12
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing12
All 1 locations
Target enrolment
to

Coronary Artery Disease trials in China

12 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT
NCT07762755Coronary Artery Disease, Hyperlipidaemia, Hypertriglyceridaemia, Coronary Atherosclerosis
China National Center for Cardiovascular Diseases
Phase 4
100
Beijing
2026-08-01
Not yet open
A Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuation
NCT07766434Coronary Artery Disease
China National Center for Cardiovascular Diseases
Observational
10,000
Beijing
2026-08
Recruiting
QFR-Guided Virtual Stenting for Preprocedural Physiological Optimization of Percutaneous Coronary Intervention: A Randomized Controlled Trial
NCT07635407Coronary Artery Disease, Coronary Stenosis, Ischemic Heart Disease
China National Center for Cardiovascular Diseases
Not applicable
1,472
Beijing
2026-06-02
Not yet open
pCAD-POAF 3 Year Follow-up
NCT07146061Coronary Artery Disease, Atrial Fibrillation
China National Center for Cardiovascular Diseases
Observational
430
Beijing
2025-08
Recruiting
24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
NCT06014060Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent, Dual Antiplatelet Therapy
China National Center for Cardiovascular Diseases
Not applicable
3,300
Beijing
2025-06-20
Recruiting
Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease
NCT06917664Coronary Artery Disease, Ischemic Mitral Regurgitation, Angiotensin Receptor/Neprilysin Inhibitor
China National Center for Cardiovascular Diseases
Phase 4
220
Beijing
2025-06-05
Recruiting
NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
NCT05638867Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome
China National Center for Cardiovascular Diseases
Phase 4
3,944
Beijing
2023-11-25
Not yet open
Radial Artery Versus No-touch Saphenous Vein
NCT06014047Coronary Artery Disease
China National Center for Cardiovascular Diseases
Not applicable
774
Beijing
2023-11-01
Recruiting
National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis
NCT05437965Coronary Artery Disease, Arteritis, In-Stent Stenosis (Restenosis) of Coronary Artery Stent
China National Center for Cardiovascular Diseases
Observational
1,000
Beijing
2020-06-03
Recruiting
Effects of Left Atrial Appendage Resection and Marshall Ligament Amputation on Clinical Outcome in Patients Undergoing Off-pump Coronary Artery Bypass
NCT04220047Coronary Artery Disease, Stroke, Atrial Fibrillation
China National Center for Cardiovascular Diseases
Not applicable
400
Beijing
2020-04-30
Active, closed
No-Touch Versus Conventional Saphenous Vein Harvesting Technique
NCT03126409Coronary Artery Disease
China National Center for Cardiovascular Diseases
Not applicable
2,655
Beijing
2017-05-14
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/condition/coronary-artery-disease

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies listing the condition Coronary Artery Disease that also match the filters currently applied.

How many Coronary Artery Disease trials are recruiting in China?

6 of the 12 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 5 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Coronary Artery Disease), 12 studies
PhaseStudiesRecruitingShare
Not applicable6350%
Observational3125%
Phase 43225%

Most active sponsors

Lead sponsors with the most studies (Coronary Artery Disease)
Lead sponsorStudiesRecruiting
China National Center for Cardiovascular Diseases126
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.